Summary

Sleep apnea, a common sleep problem that affects millions of people in North America, has increased demand for treatment devices targeted at easing symptoms and enhancing sleep quality. The market for sleep apnea therapy devices in the region has seen substantial expansion and evolution as a result of a variety of causes. The market for sleep apnea treatment devices in North America has grown dramatically as the prevalence of sleep disorders has increased. Obesity, lifestyle changes, and an ageing population have all led to an increase in the prevalence of sleep apnea, resulting in a greater demand for effective therapeutic solutions. Government measures to improve healthcare infrastructure and raise knowledge about sleep problems have been critical. These efforts have encouraged early detection and treatment, increasing demand for sleep apnea therapeutics devices. Additionally, reimbursement policies and insurance coverage for these devices have made them more accessible to a broader segment of the population. Sleep apnea prevalence rates are notably high in North America, with the disorder afflicting a sizable proportion of the population. The region's proactive approach to healthcare, as well as a strong emphasis on public health awareness initiatives, have aided in the recognition and diagnosis of sleep disorders such as sleep apnea. As a result, there is a greater need for therapeutic devices as people seek effective ways to control their disease. The region's healthcare policy and insurance coverage have a significant impact on the market. Greater insurance coverage and favourable reimbursement rules for sleep apnea diagnostic tests and therapeutic equipment have made these treatments more accessible and cheap to a greater demographic segment. This aspect has a substantial impact on adoption rates and market growth in the region.

According to the research report "North America Sleep Apnea Therapeutic Devices Market Outlook, 2028," published by Bonafide Research, the North America Sleep Apnea Therapeutic Devices market is expected to grow with more than 7% CAGR from 2023 to 2028. North America has a concentration of leading sleep medicine and respiratory health companies and research facilities. Collaboration between academics, industry, and healthcare practitioners drives therapeutic device breakthroughs. These collaborations foster innovation and contribute to the creation of more effective, user-friendly, and technologically sophisticated sleep apnea management solutions. North America maintains strong medical device regulatory standards to ensure safety, efficacy, and quality. Before accessing the market, regulatory agencies such as the FDA (Food and Drug Administration) in the United States and Health Canada ensure that sleep apnea therapy devices meet stringent standards. This emphasis on compliance and quality assurance instills confidence in the efficacy and safety of these devices in both healthcare providers and patients. Demographic factors, such as an ageing population, and lifestyle changes, such as rising obesity rates, all contribute to the prevalence of sleep apnea in North America. These demographic and lifestyle characteristics increase demand for sleep apnea treatment devices, resulting in a long-term market requirement. The combination of telemedicine and remote monitoring technology has changed the way sleep problems are diagnosed and managed in North America. Telemedicine enables remote consultations, home sleep testing, and continuous monitoring of patients with sleep apnea, improving access to care and influencing treatment decisions. A cultural shift towards self-care and personal health management has been observed in North America. Individuals are increasingly taking an active role in managing their health, seeking information, and adopting lifestyle changes to improve their well-being. This trend aligns with the use of therapeutic devices for sleep apnea, empowering individuals to take charge of their sleep health.

Based on report market is divided into three major countries United States, Canada and Mexico. United States accounts for the largest market for sleep apnea therapeutic delivery devices market.

The United States is a significant hub for the development and application of sleep apnea treatment devices, fostering a competitive market landscape characterised by innovation and technologically driven solutions. The staggering prevalence of sleep apnea in the United States, estimated to affect over 29 million adults, has boosted demand for effective therapy equipment. This regular occurrence, combined with increased awareness of the health risks associated with untreated sleep apnea, has spurred market growth. Because of the condition's proclivity to create cardiovascular issues, diabetes, and other major health issues, there is a greater need for swift and effective treatment solutions. Significant technological developments have occurred in the field of sleep apnea therapy devices. Continuous positive airway pressure (CPAP) machines, which were once the dominant therapeutic choice, have advanced significantly. These machines, which provide continual airflow to keep airways open while sleeping, have grown more user-friendly and portable, improving patient compliance. Over 5.8 million adults in the United States have been correctly diagnosed with sleep apnea. Companies are always investing in R&D to improve device efficacy, comfort, and use. Partnerships and collaborations with healthcare providers and technical innovators are becoming increasingly popular strategies for expanding market reach and offering comprehensive solutions.

Based on product market is bifurcated into positive airway pressure (PAP) device, adaptive servo-ventilation (ASV), airway clearance systems, oxygen devices, oral appliances, and others. The market of North America is majorly dominated by positive airway pressure (PAP) devices with significant market share.

PAP devices, particularly continuous positive airway pressure (CPAP), have a long history of success in the treatment of obstructive sleep apnea. Clinical studies have shown that they are helpful at keeping airways open during sleep, reducing apnea occurrences, and improving overall sleep quality. PAP devices' confirmed efficacy has cemented their status as a key therapeutic option. PAP devices, particularly CPAP, are appropriate for a wide range of sleep apnea severity levels, from mild to severe. Because of its adaptability, PAP therapy is a comprehensive treatment option that can meet the unique demands of people with varying degrees of sleep apnea. Clinical guidelines and recommendations from organisations such as the American Academy of Sleep Medicine (AASM) strongly support the use of PAP therapy, especially CPAP, as the first-line treatment for obstructive sleep apnea. These guidelines influence healthcare provider’s decisions and contribute to the widespread prescription of PAP devices. The PAP device business is always investing in R&D to increase device functionality and usability. Patient problems such as noise, mask discomfort, and portability are addressed through innovations. These developments improve user experience and compliance, adding to the market dominance of PAP devices. PAP devices are readily available and can be purchased from a variety of healthcare practitioners, clinics, durable medical equipment suppliers, and internet shops. Their extensive availability and ease of access contribute to their market dominance, ensuring that patients have access to these devices when prescribed.

In terms of end user segment market is bifurcated into home care settings & individuals and sleep laboratories and hospitals. Home care settings & individuals are major end users of sleep apnea therapeutic devices in North America and is expected to dominate the market as well.

In North America, there is a growing preference for home-based care for a variety of health concerns, including sleep disorders such as sleep apnea. When compared to hospital- or facility-based care, home care environments provide more convenience, comfort, and cost-effectiveness. Patients prefer to manage their conditions in familiar settings, which contribute to an increase in the use of treatment equipment at home. Individuals diagnosed with sleep apnea frequently want to manage their illness at home. The use of therapeutic gadgets at home improves adherence to treatment regimens. Patients report feeling more comfortable and at peace, which leads to more compliance and better treatment outcomes. Using therapy devices to manage sleep apnea at home can be less expensive than hospital-based care. Furthermore, the availability of gadgets for home use, in conjunction with insurance coverage and reimbursement policies, makes it more feasible for individuals to procure and use these devices in their homes. Home care settings facilitate personalized care plans tailored to individual patient needs. Healthcare providers can customize treatment regimens, device settings, and follow-up care according to specific patient requirements, fostering better patient engagement and satisfaction.

Companies Covered in this report:

ResMed Inc. , Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., GE HealthCare Technologies, Inc., BMC Medical Co Ltd, Invacare Corporation , Itamar Medical Ltd, Compumedics Ltd, Drive DeVilbiss Healthcare, Nihon Kohden Corporation, LivaNova, PLC , Airway Management Inc.

Considered in this report:

• Geography: North America
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• North America Sleep Apnea Therapeutic Devices market Outlook with its value and forecast along with its segments
• Country-wise Sleep Apnea Therapeutic Devices market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• United States
• Canada
• Mexico

By Product:

• Positive Airway Pressure (PAP) Devices
• Adaptive Servo-Ventilation (ASV)
• Airway Clearance Systems
• Oxygen Delivery Products
• Oral Appliances
• Others

By End User:

• Home care Settings & Individuals
• Sleep laboratories & Hospitals

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Sleep Apnea Therapeutic Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.
***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents